Cochlear Implantation Among Adults and Older Children With Unilateral or Asymmetric Hearing Loss
NCT ID: NCT02105441
Last Updated: 2018-04-05
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
40 participants
OBSERVATIONAL
2014-03-31
2018-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Study of Cochlear Implants in Adults With Asymmetrical Hearing Loss
NCT02004535
Single-Sided Deafness and Asymmetric Hearing Loss
NCT04506853
Investigation to Evaluate the Safety and Effectiveness of Cochlear Implantation in Children and Adults With Unilateral Hearing Loss/Single-sided Deafness
NCT05318417
Cochlear Implantation in Adults With Asymmetric Hearing Loss Clinical Trial
NCT03052920
Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial
NCT04793412
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This is not a funded study. All costs are billed through insurance for reimbursement. There is an insurance approval process that we move through after a participant has been evaluated at the Mayo Clinic and found to be a candidate for cochlear implantation.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
cochlear implant
How well patients with cochlear implants understand speech in noise with implant on, compared to implant off.
Cochlear implant
Implantable hearing device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cochlear implant
Implantable hearing device
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years of age or older,
* Hearing loss in the ear to be implanted must such that speech understanding is not possible with a well fitted hearing aid. Specifically, less than 40% monosyllabic word understanding when that ear is tested in the best-aided condition and the other ear is sufficiently occluded or masked.
* Onset of hearing loss in the adult group must be post-lingual (after three years of age)
Children
* Children 7 years of age and older
* Hearing loss in the ear to be implanted configured such that word understanding is less 40% in the best aided condition
* Onset of hearing loss in the pediatric group must be post-lingual (after three years of age)
7 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Mayo Clinic
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Matthew L. Carlson, M.D.
Associate Professor of Neurosurgery and Otolaryngology
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Matthew L Carlson, MD
Role: PRINCIPAL_INVESTIGATOR
Mayo Clinic
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
13-009050
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.